210 related articles for article (PubMed ID: 16334487)
21. Three hematologic malignancies in the same patient: chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemia.
Fattizzo B; Radice T; Cattaneo D; Pomati M; Barcellini W; Iurlo A
Clin Lab; 2014; 60(11):1929-32. PubMed ID: 25648037
[TBL] [Abstract][Full Text] [Related]
22. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
[TBL] [Abstract][Full Text] [Related]
23. Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of cyclin D3 down regulation.
Wang P; Pavletic ZS; Joshi SS
Leuk Lymphoma; 2002 Sep; 43(9):1827-35. PubMed ID: 12685840
[TBL] [Abstract][Full Text] [Related]
24. Expression of cyclins D-type in B-chronic lymphoproliferative disorders.
Sola B; Roué G; Duquesne F; Avet-Loiseau H; Macro M; Salaün V; Troussard X
Leukemia; 2000 Jul; 14(7):1318-9. PubMed ID: 10914560
[No Abstract] [Full Text] [Related]
25. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
26. Expression of leukocyte alkaline phosphatase gene in normal and leukemic cells: regulation of the transcript by granulocyte colony-stimulating factor.
Rambaldi A; Terao M; Bettoni S; Tini ML; Bassan R; Barbui T; Garattini E
Blood; 1990 Dec; 76(12):2565-71. PubMed ID: 1702329
[TBL] [Abstract][Full Text] [Related]
27. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.
Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J
J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124
[TBL] [Abstract][Full Text] [Related]
28. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
29. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
[TBL] [Abstract][Full Text] [Related]
30. Screening for mutations of Bcl10 in leukaemia.
Grimwade D; Du MQ; Langabeer S; Rogers J; Solomon E
Br J Haematol; 2000 Jun; 109(3):611-5. PubMed ID: 10886211
[TBL] [Abstract][Full Text] [Related]
31. Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity.
Ott MM; Bartkova J; Bartek J; Dürr A; Fischer L; Ott G; Müller-Hermelink HK; Kreipe H
Blood; 1997 Oct; 90(8):3154-9. PubMed ID: 9376597
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of curcumin on MDR1 gene expression in patient leukemic cells.
Anuchapreeda S; Thanarattanakorn P; Sittipreechacharn S; Tima S; Chanarat P; Limtrakul P
Arch Pharm Res; 2006 Oct; 29(10):866-73. PubMed ID: 17121181
[TBL] [Abstract][Full Text] [Related]
33. Cyclin alterations in giant cell tumor of bone.
Kauzman A; Li SQ; Bradley G; Bell RS; Wunder JS; Kandel R
Mod Pathol; 2003 Mar; 16(3):210-8. PubMed ID: 12640100
[TBL] [Abstract][Full Text] [Related]
34. Induction and expression of cyclin D3 in human pancreatic cancer.
Ebert MP; Hernberg S; Fei G; Sokolowski A; Schulz HU; Lippert H; Malfertheiner P
J Cancer Res Clin Oncol; 2001 Jul; 127(7):449-54. PubMed ID: 11469683
[TBL] [Abstract][Full Text] [Related]
35. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
[TBL] [Abstract][Full Text] [Related]
36. Fluorescent 5'-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias.
Kreuzer KA; Saborowski A; Lupberger J; Appelt C; Na IK; le Coutre P; Schmidt CA
Br J Haematol; 2001 Aug; 114(2):313-8. PubMed ID: 11529849
[TBL] [Abstract][Full Text] [Related]
37. Expression of c-kit receptor (CD117) and CD34 in leukemic cells.
Muroi K; Nakamura M; Amemiya Y; Suda T; Miura Y
Leuk Lymphoma; 1995 Jan; 16(3-4):297-305. PubMed ID: 7536510
[TBL] [Abstract][Full Text] [Related]
38. Deregulation of D-type cyclins in uterine cancers. Cyclin D1/D3 is differentially expressed in cervical cancer.
Skomedal H; Forus A; Holm R
Anticancer Res; 2003; 23(5A):3929-35. PubMed ID: 14666699
[TBL] [Abstract][Full Text] [Related]
39. A morphological pattern of 234 cases of leukemias.
Hassan K; Ikram N; Shah SH
J Pak Med Assoc; 1994 Jun; 44(6):145-8. PubMed ID: 8089909
[TBL] [Abstract][Full Text] [Related]
40. Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth.
Kushner JA; Ciemerych MA; Sicinska E; Wartschow LM; Teta M; Long SY; Sicinski P; White MF
Mol Cell Biol; 2005 May; 25(9):3752-62. PubMed ID: 15831479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]